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Abstract Microglia are the resident immune cells and the
professional phagocytic cells of the CNS, showing amultitude
of cellular responses after activation. However, how
microglial phagocytosis changes and whether it is involved
in radiation-induced brain injury remain unknown. In the cur-
rent study, we found that microglia were activated and
microglial phagocytosis was increased by radiation exposure
both in cultured microglia in vitro and in mice in vivo. Radi-
ation increased the protein expression of the purinergic recep-
tor P2Y6 receptor (P2Y6R) located on microglia. The selec-
tive P2Y6 receptor antagonist MRS2578 suppressed
microglial phagocytosis after radiation exposure. Inhibition
of microglial phagocytosis increased inhibitory factor Nogo-
A and exacerbated radiation-induced neuronal apoptosis and
demyelination.We also found that the levels of protein expres-
sion for phosphorylated Ras-related C3 botulinum toxin sub-
strate 1 (Rac1) and myosin light chain kinase (MLCK) were
elevated, indicating that radiation exposure activated Rac1
and MLCK. The Rac1 inhibitor NSC23766 suppressed ex-
pression of MLCK, indicating that the Rac1-MLCK pathway
was involved in microglial phagocytosis. Taken together, the-
se findings suggest that the P2Y6 receptor plays a critical role
in mediating microglial phagocytosis in radiation-induced
brain injury, which might be a potential strategy for therapeu-
tic intervention to alleviate radiation-induced brain injury.
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Introduction
Primary tumors affecting the head, neck, and brain as well as
brain metastases occurring in 20–40 % of patients with cancer
account for significant morbidity and mortality [1, 2]. Radia-
tion therapy is one of the most effective treatment modalities
for these types of tumors [3, 4]. Radiotherapy, although help-
ful in the management of central nervous system (CNS) and
head and neck tumors, can cause devastating injury to normal
CNS tissues [5, 6]. Currently, few effective strategies alleviate
this radiation-induced brain injury. Although the exact patho-
genic mechanisms of radiation-induced brain injury remain
largely unknown, studies have demonstrated that microglia
may play a pivotal role by releasing proinflammatory factors
that induce an inflammatory response when activated by radi-
ation [7, 8]. In addition to this inflammatory response aspect,
microglia are also professional phagocytes in the CNS, main-
taining homeostasis of the nervous system [9]. Following a
CNS injury, microglia become activated and phagocytose dy-
ing cells, myelin debris, and apoptotic cells [10–12]. The ef-
ficient clearance of apoptotic cells may prevent the accumu-
lation of necrotic cells and the subsequent release of
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detrimental intracellular components from these cells. Remov-
al of myelin debris also helps to clear inhibitory factors, such
as neurite outgrowth inhibitor (Nogo)-A, which block differ-
entiation of oligodendrocyte precursor cells to oligodendro-
cytes, impairing remyelination [13]. In addition to this bene-
ficial effect of microglial phagocytosis, evidence indicates that
activated microglia mediate phagocytosis of viable neurons,
leading to neuronal loss and death in models of focal brain
ischemia and AIDS dementia [14, 15]. Activated and phago-
cytic microglia are also observed accumulated at the lesion/
spinal cord interface in an irradiated hemisectioned spinal cord
[12]. However, the mechanisms underpinning microglial
phagocytosis in the pathogenesis of radiation-induced brain
injury remain to be elucidated. Some studies have shown that
extracellular uridine diphosphate (UDP) released by injured
cells serves as an “eat me” signal and acts on P2Y6 receptors
to initiate microglial phagocytosis [16]. Whether mediating
UDP/P2Y6 signaling and microglial phagocytosis can allevi-
ate radiation-induced brain injury requires further
investigation.
In the current study, we demonstrated that microglial
phagocytosis was activated after radiation both in vitro and
in vivo. Radiation increased the expression of P2Y6 receptors,
and this increase was inhibited by a P2Y6 receptor-specific
antagonist. Radiation caused neuronal apoptosis and induced
a remyelination deficiency, both of which were aggravated by
inhibiting UDP/P2Y6R signaling and microglial phagocyto-
sis. We also determined that the Ras-related C3 botulinum
toxin substrate 1 (Rac1)-myosin light chain kinase (MLCK)
pathway was involved in P2Y6R-mediated microglial phago-
cytosis in radiation-induced brain injury.
Materials and Methods
Ethical Statement
All experiments were approved by the ethical committee of
Sun Yat-Sen University. All procedures followed the guide-
lines recommended by the Chinese National Institute of
Health for humane care, which complies with the National
Institutes of Health’s Guide for the Care and Use of Labora-
tory Animals. All efforts were made to minimize animal suf-
fering, to reduce the number of animals used, and to utilize
alternatives to in vivo techniques.
Animals and Cell Culture
Adult male BALB/c mice (weighing 18–22 g) were obtained
from the Laboratory Animal Center of Sun Yat-Sen Universi-
ty. Primary microglia were cultured according to a previously
described method [17]. Briefly, a mixed glial culture was pre-
pared from neonatal BALB/c mice and maintained for 10–
20 days in medium (DMEM; Life Technologies, CA, USA)
containing 10 % fetal calf serum, 10 U/mL penicillin, and
10 mg/mL streptomycin (Life Technologies). Microglia were
obtained when cells floated over the mixed glial culture. The
floating cells were collected by gentle shaking and transferred
into appropriate dishes or glasses. The cells were used for
Western blot, immunofluorescence, and phagocytosis assays.
Irradiation Models
Cell Irradiation
The regimen of cell irradiation was based on our previous
study. We tested the radiation dose effect of 3, 5, 8, and
10 Gy and found that inflammatory mediators did not change
at 3 or 5 Gy, but increased significantly at 8 and 10 Gy. Be-
cause 8 Gy was previously shown to guarantee the cell sur-
vival, a single radiation dose of 8 Gy was used in the in vitro
experiments. Primary microglia were cultured 24–36 h. The
medium was replaced with serum-free medium 4 h before
radiation exposure. The selective P2Y6 receptor antagonist
MRS2578 (1 μmol/L; Sigma-Aldrich) was added 30 min be-
fore radiation. Cells were radiated with a linear accelerator
using β ionizing radiation (Siemens, Germany).
Animal Irradiation
Adult male BALB/c mice were anesthetized with 10% chloral
hydrate (200 mg/kg, intraperitoneal injection). The mice were
irradiated using a 6 MV linear accelerator with β ionizing
radiation (Siemens, Germany) as described previously [17].
The head of the mouse, including the whole brain from the
post-canthus line to the post-aurem line, was placed in the
treatment field (2×2 cm2). Nonirradiated tissues were
protected with a 1-cm-thick lead plate. In a previous study, a
single dose of radiation higher than 25 Gy was applied to
induce brain injury in rats [18]. Another study showed that
microglial-derived COX-2 did not increase at doses less than
25 Gy [19]. Therefore, a single dose of 30 Gy was given at a
rate of 3 Gy/min to the whole brain of mice in the present
study. The animals were either sacrificed 7, 14, and 30 days
after radiation exposure. These times were selected based on
the results of our previous study showing that alterations in
gene and protein expression occur as early as 3 days, morpho-
logical changes at 7 days. [17].
Antagonist Administration
Mice were anesthetized and positioned in a stereotaxic frame
(Lanxing, China). A guide cannula was placed in the hippo-
campal CA3 region (coordinates calculated from bregma: an-
terior, −1.94 mm; lateral, 2.0 mm; ventral, 2.0 mm) and fixed
with dental cement. One day after the operation, an injection
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cannula (1 mm longer than the guide cannula; Ruiwode, Chi-
na) was inserted through the guide cannula. The P2Y6 recep-
tor antagonist MRS2578 (100 μM/1 μL) was injected via the
guide cannula 30 min before radiation and daily for the ensu-
ing 6 consecutive days. Following the last injection of
MRS2578, 1 μL of fluorescent microspheres (yellow green,
1 μm, Sigma-Aldrich) was injected. Control mice received the
same volume of saline instead of MRS2578. The mice were
sacrificed and perfused with 4 % paraformaldehyde 48 h after
the microsphere injection.
Immunofluorescence
For immunocytochemistry, microglia were incubated with
serum-free medium for 1 h before radiation exposure. For
detection of florescent beads, primary microglia were incubat-
ed with fluorescent latex beads (1 μm, 0.0025 %, Sigma-Al-
drich) in serum-free medium for 30 min at 37 °C with and
without MRS2578 (100 μM). After incubation, the medium
was removed, and cells were fixed with paraformaldehyde for
30min. Cells were incubated with 0.5-mL 0.3% Triton X-100
for 30 min after being washed three times. Cells were incu-
bated at 4 °C overnight with rhodamine-phalloidin (1:40; Life
Biotechnology). Fluorescence images were obtained with a
fluorescence microscope (Olympus Optical, Japan).
For immunohistochemistry, the brains were removed,
placed in 4 % paraformaldehyde for 12 h, transferred to a
30 % sucrose solution for 24 h, and then sliced for immuno-
histochemical analysis. For quantitative analysis of in vivo
phagocytosis, sections (30 μm) containing microspheres were
thoroughly washed (using a shaking plate, five times for 5 min
each) with PBS to remove nonspecifically bound micro-
spheres. Then, sections were incubated in 0.3 % Triton
X-100 containing PBS (using a shaking plate, 10 times for
10 min each) and labeled with rabbit anti-Iba1 (1:500; Wako
Pure Chemical Industries, Ltd.). Images were obtained with a
confocal laser microscope (LSM5 Pascal, Carl Zeiss). The
captured images were reconstructed and stacked in the Z di-
mension. The number of microspheres in the section was
counted as an index of in vivo phagocytosis. Three sections
containing the microspheres in each animal were analyzed,
and at least three animals in each group were used. For double
immunofluorescence staining, coronal brain slices (10 μm)
were blocked with 5 % goat serum and incubated with rabbit
polyclonal anti-P2Y6 receptor (1:50; Alomone), rabbit poly-
clonal anti-Iba1 receptor (1:500, Wako Pure Chemical Indus-
tries, Ltd.), mouse monoclonal anti-GFAP (1:500, Millipore),
and mouse monoclonal anti-NeuN (1:500, Millipore) for 24 h
at 4 °C. The appropriate secondary antibodies, including goat
anti-rabbit Alexa 594, goat anti-mouse Alexa 594, and donkey
anti-rabbit Alexa 488 (all purchased from Jackson
ImmunoResearch), were incubated with the slices for
100 min at room temperature. After nuclear staining with 4′,
6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) for
8 min, sections were coverslipped with glycerol, and fluores-
cent images were obtained with a fluorescence microscope
(Olympus Optical, Japan).
Fluorescence-Activated Cell Sorting
Phagocytosis was analyzed in vitro as previously described
[20]. Briefly, microglia were plated at a density of 5×105/dish.
The fluorospheres (1-μm diameter green-yellow fluorescent
microspheres, Sigma-Aldrich, prepared as described above)
at 0.0025 % combined with the P2Y6R inhibitor or Rac1
inhibitor at various concentrations were added to the culture
for 30 min at 37 °C. The cultures were washed with PBS at
least three times. The cells were removed using EDTA solu-
tion and centrifuged at 500×g for 5 min. The cells were resus-
pended in 1-mL fluorescence activated cell sorting (FACS)
buffer. The cell suspension was evaluated using a BD FACS
Universal Loader (BD Biosciences) to analyze fluorescent
intensity, which was detected using the FITC channel
(488 nm). Data were analyzed with BD FACSuite software
and expressed as the percentage of phagocytic cells. Alterna-
tively, the cell suspension was separated using a FACSAria
cell-sorting system (BDBiosciences) to determine the number
of fluorospheres engulfed by phagocytic cells.
Terminal Deoxynucleotidyl Transferase Dutp Nick end
Labeling (TUNEL)
Apoptotic neuronal cells were detected via double stain-
ing with NeuN (1:250, Millipore) and TUNEL (FragEL
DNA Fragmentation Detection Kit, Fluorescent-TdT En-
zyme; Merck). In a separate experiment, mice were
pretreated with MRS2578 (100 μM) or saline before
radiation exposure and for the ensuing 7 days. The mice
were then sacrificed and their brains sliced into coronal
sections 10 μm thick. The ratio of apoptotic to live
neuronal cells was calculated.
Real-Time PCR
Total RNA isolation and real-time PCR were performed as
previously described [17]. Total RNAwas isolated from cells
using the RNeasy Plus Mini Kit (TaKaRa), according to the
manufacturer’s instructions. After reverse transcription, quan-
titative real-time PCR was performed using primers specific
for the genes encoding TNF-α, IL-1β, IL-6, iNOS, and
GAPDH. The following primers were used: iNOS, sense, 5′-
CTC ACT GTG GCT GTG GTC ACC TA-3′, anti-sense, 5′-
GGG TCT TCG GGC TTC AGG TTA-3′; IL-6, sense, 5′-
GTC ACA GAA GGA GTG GCT AAG GA-3′, anti-sense,
5′-TAA CGC ACT AGG TTT GCC GAG TAG-3′; TNF-α,
sense, 5′-TTG ACC TCA GCG CTG AGT TG-3′, anti-sense,
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5′-CCT GTA GCC CAC GTC GTA GC-3′; IL-1β, sense, 5′-
GCT GTG GCA GCTACC TAT GTC TTG-3′, anti-sense, 5′-
AGGTCGTCATCATCCCACGAG-3′; GAPDH, sense, 5′-
ATC TTC TTG TGC AGT GCC AG-3′, anti-sense, 5′-CGT
TGA TGG CAA CAA TCT CC-3′. PCR was performed for
10 min at 95 °C, followed by 50 cycles for 10 s at 95 °C,
annealing for 10 s at 60 °C, and extension for 20 s at 72 °C.
The mRNA expression levels were assessed using a Roche
LightCycler with a LightCycler FastStart DNAMaster SYBR
Green I kit. The results are expressed as the relative mRNA
expression of the threshold cycle value and were normalized
by parallel amplification of the endogenous control GAPDH.
The target mRNA expression level in the control group (target
mRNA/GAPDH value) was set to 100 %, and levels in other
groups were converted to fold changes by comparing them to
the control group.
Western Blotting
Total protein was prepared and quantified using primary mi-
croglia or brain tissue from mice. The P2Y6 receptor expres-
sion level after radiation exposure and the radiation-induced
p-Rac1, Rac1, andMLCK expression levels in microglia were
evaluated using Western blot analysis. Briefly, 50 μg of total
protein loaded in each lane was separated with sodium dode-
cyl sulfate polyacrylamide gel electrophoresis and transferred
to a polyvinylidene fluoride membrane (Millipore, USA)
using an electrophoretic transfer apparatus (Bio-Rad). The
membrane was blocked with 5 % bovine serum albumin in
Tris-buffered saline containing 0.05% Tween 20 (TBST). The
membrane was incubated with rabbit anti-mouse P2Y6 recep-
tor polyclonal antibody (Alomone, Israel), rabbit anti-mouse
Rac1 monoclonal antibody (Millipore, USA), rabbit anti-
rabbit phosphorylation Rac polyclonal antibody (CST,
USA), and rabbit anti-rabbit MLCK polyclonal antibody
(Abgent, USA) in blocking solution overnight at 4 °C. After
thorough washing in TBST, the membranes were incubated
with secondary antibodies, goat anti-rabbit or goat anti-mouse
IgG–horseradish peroxidase conjugate (LiankeBio, China),
and the proteins were developed using the Enhanced Chemi-
luminescence detection system (Millipore, USA) with expo-
sure to X-ray film. The relative densities of bands were ana-
lyzed with a gel imaging analysis system (Genetics Inc.,
USA).
Electron Microscopy
Mice were anesthetized with 10 % chloral hydrate and per-
fused with paraformaldehyde (4 %). The hippocampus was
removed and cut into small pieces (approximately 1 cubic
millimeter). After primary fixation of brain sections in glutar-
aldehyde (2.5 %) prepared in phosphate buffer (0.1 M, pH
7.4) and paraformaldehyde (2 %) for 4 h, postfixation was
conducted in osmium tetroxide (1 %) for 1.5 h, followed by
dehydration and embedding in resin, DDSA, NMA, and
DMP-30 medium overnight. The tissues were then baked at
65 °C for 48 h. Finally, the tissues were cut into thin sections
(60–80 nm) using an ultramicrotome (Leica, UC6/FC6). The
thin sections on copper mesh grids were stained with uranyl
acetate and lead citrate for contrast. The brain sections were
scanned using a transmission electron microscope (FEI,
Tecnai G2 Spirit Twin).
Statistical Analysis
All experiments were repeated at least three times, and the
results are presented as the mean±SEM. Statistical analyses
were performed using a one-way ANOVA followed by
Bonferroni corrections for multiple group comparisons or Stu-
dent’s t test for comparisons between two groups with SPSS
16.0 software. Resulting P values <0.05 were considered sta-
tistically significant.
Results
Radiation Activates Microglia and Increases Phagocytosis
To confirm that radiation activated microglia and to evaluate
how microglial phagocytosis changed following radiation, cul-
tured primary microglia were exposed to 8 Gy of β radiation.
Latex beads (green in Fig. 1) were added to quantitatively
evaluate microglial phagocytosis. The morphological alteration
of microglia (Iba1, red in Fig. 1) was examined using immu-
nofluorescence labeling. As shown in Fig. 1a, β radiation al-
tered the morphology of microglia from ramified to amoeboid,
with larger soma and thicker but shorter protrusions. Irradiated
cells phagocytosed more beads than control cells did, showing
a time-dependent increase.Microglial phagocytosis was further
quantified with a phagocytosis assay using FACS. As shown in
Fig. 1b, compared with the control group, there was a signifi-
cant increase in microglial phagocytosis after radiation expo-
sure. This increase was time dependent (Fig. 1c). Because the
latex beads were added 30 min before microglia were fixed for
the morphology examination or phagocytosis assay, the time
the latex beads were incubated in all groups was identical.
Therefore, phagocytosis, and not incubation time, accounted
for the difference between the groups.
We also determined whether radiation facilitated microglial
phagocytosis in vivo. BALB/c mice were irradiated with single
dose of 30 Gy to the head. Fluorescent microspheres were
injected into the hippocampus CA3 region 3 days before the
animals were sacrificed for examination. The number of micro-
spheres phagocytosed or attached to microglia was counted. As
shown in Fig. 1d, e, the number of microspheres phagocytosed
or attached to microglia significantly increased after radiation
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in a time-dependent manner. Taken together, these findings
suggest that radiation markedly activated microglia and facili-
tated microglial phagocytosis both in vitro and in vivo.
Radiation Upregulates P2Y6 Receptor Expression
After demonstrating that radiation induced microglia activa-
tion and increased phagocytosis, we next explored the under-
lying mechanisms. The purinoceptor P2Y6, a member of P2
receptor family, reportedly contributes mainly to microglial
phagocytosis in the CNS [20]. Therefore, we examined the
expression and function of the P2Y6 receptor in irradiated
microglia in vitro and in vivo. As shown in Fig. 2a, b, the
level of P2Y6R protein expression in freshly isolated microg-
lia was significantly increased after single dose of radiation
(8 Gy). This increase began 4 h after radiation and remained
elevated for 2 days. In vivo experiments confirmed the in vitro
data. Whole brain irradiation of BALB/c mice at a single dose
of 30 Gy. We examined the cell types in which the P2Y6R
protein expressed in response to radiation. Immunolabeling of
the irradiated brain revealed that the P2Y6R expression in-
crease wasconfined to microglia and was not detected in neu-
rons or astrocytes (Fig. 2c). Irradiation increased P2Y6R pro-
tein expression, beginning 7 days and remaining for 30 days
after radiation exposure (Fig. 2d, e). Thus, P2Y6R protein
expression levels are upregulated after radiation both in vitro
and in vivo.
Inhibition of P2Y6 Receptor Antagonizes
Radiation-Induced Phagocytosis
Thus far, we demonstrated that radiation induced an upregu-
lation in P2Y6R protein expression and a parallel increase in
microglial phagocytosis both in vitro and in vivo. We next
examined whether the radiation-induced enhancement of
microglial phagocytosis was mediated by the P2Y6R. As
shown in Fig. 3a, b, the radiation-induced increase in
microglial phagocytosis was blocked when microglia were
preincubated with the selective P2Y6R antagonist MRS2578
(1 μM) 1 h before radiation. However, MRS2578 alone did
Fig. 1 Radiation activates microglia and increases phagocytosis. a
Cultured microglia preincubated with fluorescent latex beads (green)
were irradiated, and then immunostained with Iba1 (red). b Cells
treated as in a were subjected to flow cytometry. Representative images
of the intensity of FITC-A staining (orange histograms) and control with
no fluorescence (green histograms) were shown. c Quantification of
percentage of microglia phagocytosing fluorescent latex beads was
shown as mean±SEM; n=3; *P<0.05 compared with unirradiated
control group. d Representative images of fluorescent microspheres
(green) attached or taken up by microglia (red, anti-Iba1) in the control
and irradiated hippocampal CA3 regions. Scale bar 50 mm. e
Quantitative analysis of phagocytosis in vivo was shown as mean±
SEM; n=3; * P<0.05 compared with unirradiated control group
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not significantly alter phagocytosis in control microglia re-
ceiving no radiation. The effect of MRS2578 was also exam-
ined in irradiated mice. MRS2578 (5 μmol/kg, once daily)
was injected into the hippocampus CA3 region for 7 consec-
utive days, starting on the day of radiation exposure. Fluores-
cent microspheres were injected 3 days before the mice were
sacrificed. As shown in Fig. 3c, d, MRS2578 significantly
inhibited the radiation-induced increase in microglial phago-
cytosis in these mice. These results indicate that the P2Y6R is
involved in the radiation-induced phagocytosis by microglia.
Thus, pharmacological inhibition of the P2Y6 receptor may
significantly suppress the radiation-induced increase in
microglial phagocytosis.
P2Y6 Receptor Antagonism Inhibits Microglial
Phagocytosis and Exacerbates Brain Injury in Irradiated
Mice
Having demonstrated that microglial phagocytosis increased
after radiation and that the P2Y6R modulated this process, we
Fig. 2 Radiation upregulates
P2Y6 receptor expression. a
P2Y6R expression in primary
mouse microglia was determined
by Western blotting 4 h, 12 h, 1,
and 2 days after radiation. b
Densitometric analysis of P2Y6R
versus GAPDH was shown as
mean±SEM; n=3; * P<0.05
compared with unirradiated
control group. c P2Y6R
colocalize with Iba1+ microglia,
but not in NeuN+ neuron, or
GFAP+ astrocytes in BALB/c
mice that received a single dose of
30Gy radiation. Scale bar 50μm.
d P2Y6R expression in mice that
received a single 30 Gy radiation
dose. e Densitometric analysis of
P2Y6R versus GAPDH. Mean±
SEM; n=3; * P<0.05 compared
with unirradiated control group
Mol Neurobiol (2016) 53:3552–3564 3557
next explored the function of this microglial phagocytosis,
that is, we investigated whether the radiation-induced increase
inmicroglial phagocytosis was beneficial or detrimental. Mice
irradiated with a single dose of 30 Gy to the head showed
increased apoptotic neurons in the cortex (Fig. 4), as identified
by increased TUNEL staining colocalized with NeuN 14 days
after radiation exposure. Administration of the P2Y6R antag-
onist MRS2578 significantly increased the number of apopto-
tic neurons. In a previous study, we showed that microglia are
activated by radiation and release proinflammatory factors,
which contribute to brain injury [17]. Because MRS2578 did
not influence the release of inflammatory mediators, such as
TNF-α, IL-1β, IL-6, or iNOS (Fig. 5a), the exacerbation of
neuronal injury observed in the present study was attributed
mainly to the decrease in microglial phagocytosis. In addition,
the radiation-induced inhibition of microglial phagocytosis
increased accumulation of Nogo-A (Fig. 5b, c) and exacerbat-
ed demyelination as shown by MBP staining (Fig. 5d, e). Our
findings from the electron microscopy analysis confirmed that
demyelination occurred after radiation and was aggravated by
the inhibition of microglial phagocytosis induced by blocking
the P2Y6 receptor with MRS2578 (Fig. 5f). Taken together,
these data suggest that microglial phagocytosis contributes to
the removal of apoptotic neurons and the inhibitory factor
Nogo-A. The efficient clearance of the injury-induced debris
is critical for the recovery of the irradiated brain that occurs
through facilitating remyelination.
Rac1-MLCK Pathway Is Involved in P2Y6
Receptor-Mediated Microglial Phagocytosis After
Radiation Exposure
Having demonstrated that the P2Y6 receptor mediates the
radiation-induced increase in microglial phagocytosis, which
protects neurons by promoting remyelination, we explored the
signaling pathways involved in microglial phagocytosis. The
initiation of phagocytosis requires the actin cytoskeleton. The
actin filaments control the formation of the phagocytic cup,
and active Rac1 has been implicated in this signaling cascade
[21]. Microglial receptor-mediated phagocytosis is dependent
Fig. 3 P2Y6 receptor mediates radiation induced microglial
phagocytosis. a Cultured microglia incubated with fluorescent latex
beads were irradiated, or pretreated with specific P2Y6R antagonist
MRS2578 before radiation. Cells were immunostained with Iba1. b
Quantitative analysis of phagocytosis in vitro. Data were shown as
mean±SEM; n=3; * P<0.05, compared with control group; # P<0.05
compared with radiation group. c Representative images of fluorescent
microspheres (green) attached or taken up by microglia (red, anti-Iba1) at
hippocampal CA3 regions in control, irradiated, MRS2578 treated mice
or irradiated mice treated with MRS2578. Scale bar 50 μm. d
Quantitative analysis of phagocytosis in vivo was shown as mean±
SEM; n=3; *P<0.05 compared with control group. # P<0.05
compared with radiation group
Fig. 4 Inhibition of P2Y6 receptor exacerbates neuronal apoptosis. a
Representative cortex sections were immunostained with anti-NeuN
(red) and TUNEL (green). Scale bar 50 μm. b Quantitative analysis of
percentage of apoptotic neurons were shown as mean±SEM; n=3; *
P<0.05 compared with control group; # P<0.05 compared with
radiation group
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on cytoskeletal MLCK [22]. To determine whether Rac1 and
MLCK pathways participate in microglial phagocytosis, we
first examined the expression of MLCK and phosphorylated
Rac1 in irradiated cultured microglia. As shown in Fig. 6a, b,
the level of phosphorylated Rac1 protein expression was in-
creased, peaking 12 h after radiation. By contrast, the
Fig. 5 P2Y6 receptor antagonism exacerbates radiation induced brain
injury. a Lysates of microglia treated as indicated for 24 h (ctrl, control;
rad, radiation; MRS, MRS2578) were subjected to real-time quantitative
PCR with the primers of TNF-α, IL-6, IL-1β, and iNOS (GAPDH as
loading control). The results were quantified and the levels in control
group compared to GAPDH were set 100 %, the fold changes in other
groups were shown. b Representative cortex sections were
immunostained with anti-Nogo-A antibody (red). Scale bar 50 μm.
Quantified data were shown in c as mean±SEM; n=3; * P<0.05
compared with control group; # P<0.05 compared with radiation
group. d Representative cortex sections were immunostained with anti-
MBP (green) antibody. Scale bar 50 μm. Statistical data were shown in e
as mean±SEM; n=3; * P<0.05 compared with control group; # P<0.05
comparedwith radiation group. fRepresentative images of demyelination
were shown by electron microscope scanning after radiation. Arrows
indicated the demyelination changes after radiation or pretreated with
MRS2578
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expression of total Rac1 did not change. The protein expres-
sion of MLCK (two subunits, 210 and 105 kD) also increased
after radiation (Fig. 6c, d). These increases in phosphorylated
Rac1 (Fig. 7a, c) andMLCK expression (Fig. 7b, d) were both
blocked by preincubation with the P2Y6R antagonist
MRS2578 (1 μM) in cultured microglia 1 h before radiation
exposure, indicating that both Rac1 and MLCK are down-
stream effectors of the P2Y6R. Treatment with the Rac1 in-
hibitor NSC23766 [23] markedly decreased the protein ex-
pression of phosphorylated Rac1 (Fig. 7e, f) and MLCK
(Fig. 7g, h), indicating that MLCK was downstream of
Rac1. Taken together, these results indicate that the Rac1-
MLCK pathway participates in the radiation-induced P2Y6
receptor-mediated microglial phagocytosis.
Discussion
Microglial activation plays a critical role in the pathogenesis
of radiation-induced brain injury. In this study, we showed that
microglial phagocytosis increased after radiation, efficiently
removing the inhibitory factor Nogo-A from the myelin debris
and engulfing apoptotic neurons. This increase in microglial
phagocytosis was paralleled by an increase in the expression of
the P2Y6 receptor protein specifically localized to microglia.
Inhibition of the P2Y6 receptor with the antagonist MRS2578
suppressedmicroglial phagocytic capacity, and this was follow-
ed by an increase in the number of apoptotic neurons and an
exacerbation of the remyelination deficit that occurs after radi-
ation exposure. The clearance of dying cells, myelin debris, and
the associated inhibitory factor Nogo-A is important for the
recovery of radiation-induced brain injury. We also found that
the Rac1-MLCK signaling pathway is involved in the increased
P2Y6R-mediated microglial phagocytosis observed in
radiation-induced brain injury. The mechanism mediating this
increased phagocytosis in brain injury is shown in Fig. 8. First,
the efficient removal of apoptotic cells may reduce the release
of proinflammatory factors and detrimental substances, such as
ATP. Second, the clearance of myelin debris and inhibitory
factors such as Nogo-A favors axonal regeneration. In addition,
becauseNogo-A impedes the differentiation of oligodendrocyte
precursor cells to oligodendrocytes, timely removal of Nogo-A
may promote remyelination and improve recovery after radia-
tion injury. To our knowledge, this is the first study to investi-
gate the microglial phagocytosis phenotype and its function in
radiation-induced brain injury.
Fig. 6 Radiation activates Rac1 and MLCK. a Phosphorylated Rac1 (p-
Rac1), Rac1 protein expression in primary mouse microglia were
determined by Western blotting 0, 4, 12, 24, or 48 h after radiation. b
Densitometric analyses of p-Rac1 and Rac1 versus GAPDHwere shown.
Mean±SEM; n=5; * P<0.05 compared with unirradiated control group.
cMLCK protein expression in primary mouse microglia were determined
by Western blotting 0, 4, 12, 24, or 48 h after radiation. d Densitometric
analyses of MLCK (210 and 105 kD subunit) versus GAPDH were
shown. Mean±SEM; n=6; * P<0.05, 210 kD subunit of MLCK versus
control; # P<0.05, 105 kD subunit of MLCK versus control
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Numerous studies have examined the chemotaxis and para-
crine effects in microglia; yet, relatively few studies have ex-
amined microglial phagocytosis. Thus, whether microglial
phagocytosis plays a beneficial or detrimental role in brain
diseases remains controversial. Studies have shown that effi-
cient clearance of tissue debris and apoptotic cells is crucial
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for reconstructing and reorganizing neuronal networking after
an insult to the brain [14–16]. In acute brain injury, microglial
phagocytosis may benefit axonal regeneration and restoration
of the microenvironment, which may help in the recovery
from brain injury [24–26]. Our study is consistent with this
concept. Yet, Neher and colleagues showed that inhibiting
microglial phagocytosis by blocking P2Y6 receptors can pre-
vent neuronal loss and death induced by lipopolysaccharide
(LPS) in culture and in vivo, suggesting a detrimental effect of
microglial phagocytosis [27]. However, in that study, the path-
ological models tested were “stressed-but-functional” neu-
rons, which were induced by LPS or lipoteichoic acid, rather
than models of neurological disease. Therefore, in their exper-
iment, activated microglia phagocytosed stressed-but-viable
neurons, not apoptotic neurons or cell debris. These authors
stated that it would also be important to test the function of
microglial phagocytosis in animal models of neurological dis-
ease. In an animal model of radiation-induced brain injury,
there are stressed-but-viable neurons as well as numerous dy-
ing cells, myelin debris, inhibitory factors such as Nogo-A,
and antigens derived from the dying cells [28–30]. These are
the main components phagocytosed by activated microglia. In
this scenario, microglia serve as the trash collectors of the
brain, helping to remove dying cells and debris to avoid a
secondary inflammatory response.
Growing evidence indicates that nucleotides play an impor-
tant role in neuron-glia communication through P2
purinoceptors, and UDP is recognized as a key molecule in
cells associated with many neurodegenerative diseases [31].
In general, phagocytosis requires the activation of several sig-
naling pathways, including the exposure of “eat-me” signals
on the target cells and their detection by cell surface receptors
on the phagocyte [32]. It was recently demonstrated in ani-
mals treated with kainite that UDP released from neurons is
required to trigger formation of the phagocytic cup in adjacent
microglia, via P2Y6 receptors [33]. However, whether the
P2Y6 receptor is involved in radiation-induced brain injury
remains unknown, which become the subject of this study. In
addition to the P2Y6 receptor, various other receptor types
initiate microglial phagocytosis under different treatments,
such as toll-like receptors (TLRs) and triggering receptor
expressed on myeloid cells 2 (TREM-2). By contributing to
phagocytosis, TLRs have been implicated in a variety of ce-
rebral disorders, including bacterial or viral infections, neuro-
degenerative disorders, inflammatory demyelinating disorders
such as multiple sclerosis, and spinal cord injury as well as in
development or physiological processes such as neurogenesis,
learning, and memory [34–36]. Whether and how TLRs and
TREM-2 are involved in radiation-induced brain injury re-
main to be elucidated in the future.
In epilepsy, Alzheimer’s disease, and Parkinson’s disease,
phagocytosis of apoptotic cells is considered beneficial for
repairing CNS damage [37]. Myelin proteins, such as Nogo-
A, myelin-associated glycoprotein, and oligodendrocyte my-
elin glycoprotein, translocate to the cell surface at the injured
Fig. 7 Rac1-MLCK pathway is involved in P2Y6 receptor-mediated
microglial phagocytosis after radiation exposure. a, b p-Rac1, Rac1,
and MLCK protein expression in primary mouse microglia were
determined by Western blotting 4 h, 24 h after radiation, with or
without treatment of MRS2578. c, d Densitometric analyses of p-Rac1,
Rac1, and MLCK versus GAPDH were shown. Mean±SEM; n=3; *
P<0.05 compared with unirradiated control group. # P<0.05 radiated
cells pretreated with MRS2578 compared with radiation group 4 h after
radiation; ## P<0.01 radiated cells pretreated with MRS2578 compared
with radiation group 24 h after radiation. △P<0.05, radiated cells
pretreated with MRS2578 compared with radiation group after radiation
(105 kD subunit of MLCK); e, g p-Rac1, Rac1, and MLCK protein
expression in primary mouse microglia were determined by Western
blotting 4 h, 24 h after radiation, with or without treatment of
NSC23766. f, h Densitometric analyzes of p-Rac1, Rac1, and MLCK
versus GAPDH were shown as mean±SEM; n=3; * P<0.05 compared
with unirradiated control group. # P<0.05 radiated cells pretreated with
NSC23766 compared with radiation group 4 h after radiation; ## P<0.01
radiated cells pretreated with NSC23766 compared with radiation group
24 h after radiation. △P<0.05, radiated cells pretreated with NSC23766
compared with radiation group after radiation (105 kD subunit ofMLCK)
Fig. 8 Diagram model for P2X7R mediated microglial activation and phagocytosis in radiation-induced brain injury
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myelin and act as inhibitors of axonal regeneration [38]. Thus,
microglial phagocytosis of damaged myelin and cell debris
would benefit the survival of injured neurons and myelin re-
generation in many neuronal diseases [39, 40]. Indeed, elevat-
ed microglial phagocytosis of myelin debris was found to
decrease dead cells, resulting in prominent functional recov-
ery [41]. We showed in the present study that when microglial
phagocytosis was suppressed, the radiation-induced myelin
injury was aggravated, suggesting that phagocytosis promotes
neural repair by reducing Nogo-A and by enhancing
remyelination. However, a study examining neonatal focal
stroke showed that microglial phagocytosis decreases in focal
areas with large amounts of neuronal apoptosis [42], plausibly
due to the severe damage caused by an overproduction of
inflammatory cytokines that inhibit phagocytosis. Therefore,
the capacity of microglial phagocytosis varies depending on
the stimulation.
Microglial phagocytosis relies on various cell surface
receptors and downstream signaling pathways, which ul-
timately modulate the actin cytoskeleton dynamics and
engulfment of damaging debris. A variety of different
proteins or signaling pathways that mediate microglial
phagocy tos i s has been repor ted , such as the
TLRs/IRAK4/p38 pathway [43], TREM2/DAP12 path-
way [44], or P2Y6 receptor/Ca2+ pathway [20]. The
signaling pathways that participate in P2Y6R-mediated
phagocytosis following radiation-induced brain injury
are unclear. Microglial phagocytosis requires the modu-
lation of the cytoskeleton [21]. Previous studies have
shown that Rac1 and MLCK participate in the regula-
tion of myosin light chain relaxation and contraction
[20]. Rac1, a protein of the Rho family GTPases, regu-
lates both neuronal apoptosis and action cytoskeleton
[45]. MLCK is a serine/threonine-specific protein kinase
that phosphorylates the regulatory light chain of myosin
II. MLCK enables the myosin to cross-bridge with actin
filaments and allows contraction to begin. Gitik et al.
repor ted tha t when MLCK was act iva ted, the
nonopsonized myelin was phagocytosed effectively
[22]. We showed here that Rac1 and MLCK were in-
volved in P2Y6R-mediated microglial phagocytosis in
radiation-induced brain injury.
In summary, our results provided the first evidence of
microglial phagocytosis in radiation-induced brain injury
in vitro and in vivo. We showed that P2Y6 receptor-
mediated phagocytosis benefits damaged neurons by the effi-
cient removal of apoptotic cells, engulfment of myelin debris,
and promotion of remyelination. The Rac1/MLCK pathway
lies downstream of the P2Y6 receptor in these processes. We
concluded that P2Y6 receptor-mediated microglial phagocy-
tosis in radiation-induced brain injury provides a new insight
for therapeutic intervention to restore neuronal survival and
brain function.
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